Deliberate self-harm and antidepressant drugs
- 1 December 2000
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 177 (6) , 551-556
- https://doi.org/10.1192/bjp.177.6.551
Abstract
Background: It is not clear if the frequency of deliberate self-harm (DSH) is the same in patients taking different pharmacological classes of antidepressant drugs.Aims: To compare the frequency of DSH in patients who had been prescribed a tricyclic antidepressant (TCA) or a selective serotonin reuptake inhibitor (SSRI) prior to the DSH event.Method: This was a prospective study in 2776 consecutive DSH cases attending an accident and emergency department. The incidence of DSH in TCA-treated cases and SSRI-treated cases is expressed as number of DSH events per 10 000 prescriptions of each antidepressant.Results: Significantly more DSH events occurred following the prescription of an SSRI than that of a TCA (P < 0.001). The occurrence of DSH was highest with fluoxetine and lowest with amitriptyline.Conclusions: Merely prescribing safer-in-overdose antidepressants is unlikely to reduce the overall morbidity from DSH.Keywords
This publication has 18 references indexed in Scilit:
- The occurrence of suicide following the prescription of antidepressant drugsArchives of Suicide Research, 1999
- Trends in deliberate self-harm in Oxford, 1985–1995The British Journal of Psychiatry, 1997
- Changing patterns of self-poisoning in a UK health districtQJM: An International Journal of Medicine, 1996
- Presentation of poisoned patients to accident and emergency departments in the North of EnglandHuman & Experimental Toxicology, 1996
- The compliance with antidepressants in general practiceJournal of Psychopharmacology, 1994
- Antidepressant Drugs and the Emergence of Suicidal TendenciesDrug Safety, 1993
- Fluoxetine and Suicidal BehaviourThe British Journal of Psychiatry, 1992
- Antidepressants - Do they Decrease or Increase Suicidality?Pharmacopsychiatry, 1992